| Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma (NCT04460235) | Poitiers University Hospital | 2021-09-07 |
| An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, Malawi (NCT04078997) | University of Liverpool | 2019-07-21 |
| Carriage of Streptococcus Pneumoniae in Infants With Acute Otitis Media and in Infants Attending Day-care Centers (NCT02888457) | Pierre Van Damme | 2015-10-01 |
| PCV10 Immunogenicity Study Nepal 2015 (NCT02385513) | University of Oxford | 2015-08-21 |
| Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years (NCT02215863) | Korea University Guro Hospital | 2014-09-01 |
| Community Acquired Pneumonia: Outcome, Quality of Life and Immune Status (NCT02141009) | St. Antonius Hospital | 2014-04-01 |
| Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine (NCT01995617) | Genocea Biosciences, Inc. | 2013-11-01 |
| Neisseria Meningitidis Burden of Disease Study (NCT01730391) | GlaxoSmithKline | 2013-01-01 |
| Costa Rica Epidemiological Study on S. Pneumoniae (NCT01308827) | Instituto de Atención Pediátrica | 2011-03-01 |
| Evaluating Vaccine Responses in Healthy Infants Receiving Their Routine Primary Immunisation According to the Accelerated United Kingdom Schedule at 2, 3 and 4 Months (NCT01425372) | Prof. Elizabeth Miller | 2010-11-01 |
| Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan) (NCT01521897) | Pfizer | 2010-09-01 |
| Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™ (NCT00907777) | GlaxoSmithKline | 2009-06-23 |
| Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease (NCT00861380) | GlaxoSmithKline | 2009-05-04 |
| Impact of the 7 Valent Pneumococcal Conjugate Vaccine (7vPCV) on Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Jordanian Infants (NCT00900978) | German-Jordanian University | 2009-05-01 |
| Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age (NCT00814710) | GlaxoSmithKline | 2009-03-07 |
| Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A (NCT00839254) | GlaxoSmithKline | 2009-02-18 |
| Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults (NCT00814489) | GlaxoSmithKline | 2009-01-08 |
| Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar (NCT00594347) | Sanofi Pasteur, a Sanofi Company | 2007-11-01 |
| Immunogenicity of PCV-7 Vaccine in VLBW Infants (NCT00273325) | NICHD Neonatal Research Network | 2004-07-01 |
| Evaluation of the Immunogenicity and Reactogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults (NCT00197821) | Public Health England | 2004-01-01 |
| Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting (NCT00622843) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2002-12-01 |
| Immunogenicity of a Reduced Primary Schedule for Pneumococcal Conjugate Vaccine in UK Infants (NCT00197769) | Public Health England | 2000-09-01 |